News
The day at a glance · 3 min read
Mood · Selective
+35
Sentiment, −100 to +100
McDonald's Franchised Target
98%
Restaurant Sector
Zevia Q3 Net Sales
$48.3M
Consumer Staples
General Motors Stock Gain (1 Week)
12%+12%
Automotive
Key driverRestaurant stocks rallied on value-driven traffic strategies while consumer staples demonstrated sustained pricing power amid mixed retail signals
Daily briefConsumer· Money365.Market AI ·

Restaurant & Staples Rally as Value Strategy Takes Hold

McDonald's rebounds on value menu push while Chipotle extends same-store sales turnaround; Coca-Cola pricing power in focus

Restaurant Sector

Bullish
01MCD▲ +6.53%
McDonald's ($MCD) reported a 0.2 percent decline in domestic same-store sales during the third quarter, although performance improved as the period progressed. The burger chain is preparing a major push to win back value-conscious customers in the U.S., with new affordable menu options, expanded digital deals, and restaurant improvements expected to drive stronger performance in 2027. Management's long-term margin strategy rests on achieving a 98% franchised target, with baseline traffic key to sustaining the model through 2028.
02CMG▲ +5.83%
Chipotle Mexican Grill ($CMG) continued its turnaround with another quarter of positive same-store sales growth. The fast-casual chain faces ongoing competitive pressures but has demonstrated improved operational execution.

Consumer Staples

Bullish
01KO
Coca-Cola ($KO) demonstrated sustained pricing power with the ability to raise prices while still selling more drinks, a key attribute for long-term investors in the beverage sector. The company's pricing strategy continues to support margin expansion despite broader inflationary pressures affecting input costs.
02ZVIA
Zevia PBC ($ZVIA) beat expectations with $48.3 million in Q3 net sales, narrowed its adjusted EBITDA loss, and secured fresh capital to fuel its strategic reset despite a cautious Q4 outlook. The zero-calorie beverage maker delivered strong quarterly performance as it executes a turnaround strategy.

Automotive

Neutral

GM Normalized EPS Estimate

$16
01F
Ford ($F) reported third-quarter sales that slipped, but the automaker saw a silver lining as customers opted for higher-margin trims and models. The trend toward premium configurations helped offset volume declines and supported profitability during the period.
02TSLA
General Motors stock rose 12% in a week to a 52-week high, as raised outlook from competitors and midterm election results sent investors toward Detroit and away from Tesla ($TSLA). Consensus estimates have the automaker's normalized EPS rising to $16.
03TSLA
Tesla ($TSLA) faced analyst warnings over potential risks from an all-stock deal premium, with one analyst citing declines of 27% in Lumentum and 31% in acquirer Marvell as precedents for how premiums can disappear in stock-based transactions.

Retail

Neutral

Home Depot Stock Gain (1 Week)

12%+12%
COSTAMZNHD
01COST
Costco ($COST) trades at a premium valuation compared to Amazon.com ($AMZN), with the discount normally reversed between the two retailers. Investors appear to be thinking defensively, favoring the warehouse club's membership model over broader e-commerce exposure.
02
Traeger reported a 40% decline in third-quarter revenue as lower grill sales, channel changes and pressure on its MEATER business weighed on results. The outdoor cooking products company narrowed its full-year revenue and adjusted EBITDA outlooks while maintaining the midpoint of each range.
03HD▲ +6.53%
Home Depot ($HD) stock rose 12% in a week, with most of the gain occurring after housing stocks rallied following the midterm elections. The home improvement retailer benefited from renewed optimism about housing market conditions.

Apparel & Health

Neutral

FIGS Stock YTD Gain

93%+93%

Usana Haya Subscriber Growth (Sequential)

18%+18%

Usana Full-Year Adjusted EBITDA Outlook

$77M
USNA
01
FIGS reports third-quarter results after the close, with its stock up 93% in 2026 and trading at more than 60x forward earnings. The medical apparel company faces high investor expectations after a 204% run.
02USNA
Usana Health Sciences ($USNA) trimmed its full-year adjusted EBITDA outlook to about $77 million even as Haya subscribers jumped 18% sequentially and Southeast Asia Pacific returned to growth. The nutritional supplement company demonstrated mixed regional performance during the quarter.

Important Disclaimer — Not Investment Advice

Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.

Read the full disclaimer — 8 further points, including total-loss risk, our regulatory status and conflicts of interest

Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.

  • You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
  • Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
  • Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
  • Automated content. This brief was compiled by an automated pipeline from validated news and market-data sources and passed through editorial and compliance checks. Automated content can still contain errors — verify anything you intend to rely on.
  • We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
  • Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
  • Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.

Full terms: Disclaimer · Terms of Service · Privacy Policy